Latest Market Research Reports

  The global immunoassay market size was estimated at USD 28.05 billion in 2025 and is projected to reach USD 40.25 billion by 2033, growing at a CAGR of 4.63% from 2026 to 2033. The market is primarily driven by the increasing demand for precision medicine across healthcare systems worldwide. As healthcare providers focus on delivering personalized treatment strategies, immunoassays have become essential diagnostic tools for identifying disease-specific biomarkers and monitoring patient responses to therapies. These assays play a critical role in tailoring treatments to individual patients by detecting biological markers that help predict responses to specific therapeutic interventions. The growing prevalence of chronic diseases, advancements in diagnostic technologies, and rising adoption of personalized healthcare approaches are further contributing to the expansion of the immunoassay market. Download a free sample copy of the Immunoassay market report to understand detailed c...

  Immunoassay Market Summary The global  immunoassay market  size was estimated at USD 26.83 billion in 2024 and is projected to reach USD 35.10 billion by 2030, growing at a CAGR of 4.59% from 2025 to 2030. Immunoassay play an essential role in supporting personalized medicine by helping identify biomarkers that indicate how individual patients may respond to specific treatments. This enables clinicians to select therapies that are better suited to each patient’s genetic and biological profile. The rising prevalence of cancer, cardiovascular disorders, and autoimmune diseases has significantly increased the demand for targeted therapeutic approaches. Immunoassay assist in determining which treatments are most likely to be effective, thereby reducing unwanted side effects and improving overall treatment outcomes. This transition from generalized treatment strategies to a more patient-specific approach is one of the main factors driving market expansion. Furthermore, pharm...

Immunoassay Industry Overview The global immunoassay market size was valued at USD 28.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2022 to 2030.  The market growth can be attributed to the increase in chronic and infectious diseases, including the outbreak of COVID-19. In addition, the rise in the geriatric population, which is more prone to chronic and infectious diseases, will aid growth. An increase in the prevalence of chronic conditions, such as cancer, infections, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases, has led to the wide usage of immunoassay techniques in disease diagnostics. The incidence of cancer is increasing steadily, which is expected to drive the demand for effective diagnostic methods such as immunoassay. This technique is significant in the determination of oncogenesis and diagnosis of cancer, such as benign or malignant, and its different stages. It facilitat...